Corrigendum to “A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation” [Eur J Canc 131 (2020) 68–75]

Corrigendum to “A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation” [Eur J Canc 131 (2020) 68–75]

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cancer (1990) 2021-02, Vol.144, p.400-400
Hauptverfasser: Lala, Mallika, Li, Tommy Ruosi, de Alwis, Dinesh P., Sinha, Vikram, Mayawala, Kapil, Li, Mengyao, Yamamoto, Noboru, Siu, Lillian L., Chartash, Elliot, Aboshady, Hesham, Jain, Lokesh
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 400
container_issue
container_start_page 400
container_title European journal of cancer (1990)
container_volume 144
creator Lala, Mallika
Li, Tommy Ruosi
de Alwis, Dinesh P.
Sinha, Vikram
Mayawala, Kapil
Li, Mengyao
Yamamoto, Noboru
Siu, Lillian L.
Chartash, Elliot
Aboshady, Hesham
Jain, Lokesh
description
doi_str_mv 10.1016/j.ejca.2020.12.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2501260408</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0959804920314180</els_id><sourcerecordid>2501260408</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2736-e8709f64df3105b6f20e99d793f3f7a7bba184e8a9a7ac600cf0abbae81b72e63</originalsourceid><addsrcrecordid>eNp9kc9u1DAQxiMEokvhBTigkbi0hyxjJ3ESiUu1Kv9UCSGBOCBkOfak9ZLEi520lNO-A1d4C55onwSnWzhy8mjmN9_o85ckjxkuGTLxbL2ktVZLjjw2-BJR3EkWrCrrFKuC300WWBd1WmFeHyQPQlgjYlnleD85yLKc5SiKRfJ75by35zSYqYfRwW778wSC_ZZeEX3pruHonfh4DMYFO5xD0Bdkpo6gdR421Dfedfb71KsG7AAbNVoaxgBXdrwArQZNHhoVyIAbgC5VN0UiltONWO8Mdd1cqcHEk_3U3Yx321_w6XTy8AZWUQNYxuBo9ngMotptf5TF54fJvVZ1gR7dvofJhxen71ev0rO3L1-vTs5SzctMpFSVWLciN23GsGhEy5Hq2pR11mZtqcqmUazKqVK1KpUWiLpFFZtUsabkJLLD5Oled-Pd14nCKNdu8kM8KXmBjAvMsYoU31PauxA8tXLjba_8tWQo56DkWs5BydmEZFzGoOLSk1vpqenJ_Fv5m0wEnu8BigYvLXkZdPxeTcZ60qM0zv5P_w-xMqa0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2501260408</pqid></control><display><type>article</type><title>Corrigendum to “A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation” [Eur J Canc 131 (2020) 68–75]</title><source>Access via ScienceDirect (Elsevier)</source><creator>Lala, Mallika ; Li, Tommy Ruosi ; de Alwis, Dinesh P. ; Sinha, Vikram ; Mayawala, Kapil ; Li, Mengyao ; Yamamoto, Noboru ; Siu, Lillian L. ; Chartash, Elliot ; Aboshady, Hesham ; Jain, Lokesh</creator><creatorcontrib>Lala, Mallika ; Li, Tommy Ruosi ; de Alwis, Dinesh P. ; Sinha, Vikram ; Mayawala, Kapil ; Li, Mengyao ; Yamamoto, Noboru ; Siu, Lillian L. ; Chartash, Elliot ; Aboshady, Hesham ; Jain, Lokesh</creatorcontrib><identifier>ISSN: 0959-8049</identifier><identifier>EISSN: 1879-0852</identifier><identifier>DOI: 10.1016/j.ejca.2020.12.006</identifier><identifier>PMID: 33414065</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><ispartof>European journal of cancer (1990), 2021-02, Vol.144, p.400-400</ispartof><rights>2020 Elsevier Ltd</rights><rights>Copyright Elsevier Science Ltd. Feb 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2736-e8709f64df3105b6f20e99d793f3f7a7bba184e8a9a7ac600cf0abbae81b72e63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejca.2020.12.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,782,786,3554,27933,27934,46004</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33414065$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lala, Mallika</creatorcontrib><creatorcontrib>Li, Tommy Ruosi</creatorcontrib><creatorcontrib>de Alwis, Dinesh P.</creatorcontrib><creatorcontrib>Sinha, Vikram</creatorcontrib><creatorcontrib>Mayawala, Kapil</creatorcontrib><creatorcontrib>Li, Mengyao</creatorcontrib><creatorcontrib>Yamamoto, Noboru</creatorcontrib><creatorcontrib>Siu, Lillian L.</creatorcontrib><creatorcontrib>Chartash, Elliot</creatorcontrib><creatorcontrib>Aboshady, Hesham</creatorcontrib><creatorcontrib>Jain, Lokesh</creatorcontrib><title>Corrigendum to “A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation” [Eur J Canc 131 (2020) 68–75]</title><title>European journal of cancer (1990)</title><addtitle>Eur J Cancer</addtitle><issn>0959-8049</issn><issn>1879-0852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kc9u1DAQxiMEokvhBTigkbi0hyxjJ3ESiUu1Kv9UCSGBOCBkOfak9ZLEi520lNO-A1d4C55onwSnWzhy8mjmN9_o85ckjxkuGTLxbL2ktVZLjjw2-BJR3EkWrCrrFKuC300WWBd1WmFeHyQPQlgjYlnleD85yLKc5SiKRfJ75by35zSYqYfRwW778wSC_ZZeEX3pruHonfh4DMYFO5xD0Bdkpo6gdR421Dfedfb71KsG7AAbNVoaxgBXdrwArQZNHhoVyIAbgC5VN0UiltONWO8Mdd1cqcHEk_3U3Yx321_w6XTy8AZWUQNYxuBo9ngMotptf5TF54fJvVZ1gR7dvofJhxen71ev0rO3L1-vTs5SzctMpFSVWLciN23GsGhEy5Hq2pR11mZtqcqmUazKqVK1KpUWiLpFFZtUsabkJLLD5Oled-Pd14nCKNdu8kM8KXmBjAvMsYoU31PauxA8tXLjba_8tWQo56DkWs5BydmEZFzGoOLSk1vpqenJ_Fv5m0wEnu8BigYvLXkZdPxeTcZ60qM0zv5P_w-xMqa0</recordid><startdate>202102</startdate><enddate>202102</enddate><creator>Lala, Mallika</creator><creator>Li, Tommy Ruosi</creator><creator>de Alwis, Dinesh P.</creator><creator>Sinha, Vikram</creator><creator>Mayawala, Kapil</creator><creator>Li, Mengyao</creator><creator>Yamamoto, Noboru</creator><creator>Siu, Lillian L.</creator><creator>Chartash, Elliot</creator><creator>Aboshady, Hesham</creator><creator>Jain, Lokesh</creator><general>Elsevier Ltd</general><general>Elsevier Science Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>202102</creationdate><title>Corrigendum to “A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation” [Eur J Canc 131 (2020) 68–75]</title><author>Lala, Mallika ; Li, Tommy Ruosi ; de Alwis, Dinesh P. ; Sinha, Vikram ; Mayawala, Kapil ; Li, Mengyao ; Yamamoto, Noboru ; Siu, Lillian L. ; Chartash, Elliot ; Aboshady, Hesham ; Jain, Lokesh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2736-e8709f64df3105b6f20e99d793f3f7a7bba184e8a9a7ac600cf0abbae81b72e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lala, Mallika</creatorcontrib><creatorcontrib>Li, Tommy Ruosi</creatorcontrib><creatorcontrib>de Alwis, Dinesh P.</creatorcontrib><creatorcontrib>Sinha, Vikram</creatorcontrib><creatorcontrib>Mayawala, Kapil</creatorcontrib><creatorcontrib>Li, Mengyao</creatorcontrib><creatorcontrib>Yamamoto, Noboru</creatorcontrib><creatorcontrib>Siu, Lillian L.</creatorcontrib><creatorcontrib>Chartash, Elliot</creatorcontrib><creatorcontrib>Aboshady, Hesham</creatorcontrib><creatorcontrib>Jain, Lokesh</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><jtitle>European journal of cancer (1990)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lala, Mallika</au><au>Li, Tommy Ruosi</au><au>de Alwis, Dinesh P.</au><au>Sinha, Vikram</au><au>Mayawala, Kapil</au><au>Li, Mengyao</au><au>Yamamoto, Noboru</au><au>Siu, Lillian L.</au><au>Chartash, Elliot</au><au>Aboshady, Hesham</au><au>Jain, Lokesh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Corrigendum to “A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation” [Eur J Canc 131 (2020) 68–75]</atitle><jtitle>European journal of cancer (1990)</jtitle><addtitle>Eur J Cancer</addtitle><date>2021-02</date><risdate>2021</risdate><volume>144</volume><spage>400</spage><epage>400</epage><pages>400-400</pages><issn>0959-8049</issn><eissn>1879-0852</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>33414065</pmid><doi>10.1016/j.ejca.2020.12.006</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0959-8049
ispartof European journal of cancer (1990), 2021-02, Vol.144, p.400-400
issn 0959-8049
1879-0852
language eng
recordid cdi_proquest_journals_2501260408
source Access via ScienceDirect (Elsevier)
title Corrigendum to “A six-weekly (Q6W) dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation” [Eur J Canc 131 (2020) 68–75]
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-02T05%3A49%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Corrigendum%20to%20%E2%80%9CA%20six-weekly%20(Q6W)%20dosing%20schedule%20for%20pembrolizumab%20in%20patients%20with%20cancer%20based%20on%20evaluation%20using%20modelling%20and%20simulation%E2%80%9D%20%5BEur%20J%20Canc%20131%20(2020)%2068%E2%80%9375%5D&rft.jtitle=European%20journal%20of%20cancer%20(1990)&rft.au=Lala,%20Mallika&rft.date=2021-02&rft.volume=144&rft.spage=400&rft.epage=400&rft.pages=400-400&rft.issn=0959-8049&rft.eissn=1879-0852&rft_id=info:doi/10.1016/j.ejca.2020.12.006&rft_dat=%3Cproquest_cross%3E2501260408%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2501260408&rft_id=info:pmid/33414065&rft_els_id=S0959804920314180&rfr_iscdi=true